Neurology News

The National Institute of Neurological Disorders and Stroke has awarded a grant to researchers at Hackensack Meridian Neuroscience Institute to study a novel approach to improving outcomes after TBI.

A European clinical stage biotech company announced dosing of the first patient in cohort 2 of its ongoing phase 1/2 GATEWAY clinical trial of lead candidate VTX-801 to treat Wilson’s disease.

Among Hispanic women, gestational hypertension was associated with decreased processing speed and executive functioning after age 45 years, according to results of an analysis published in Obstetrics & Gynecology.

Philips Respironics and Philips Holding USA agreed to the FDA’s finalized consent decree against the company, according to a company press release.

The FDA approved two new delivery methods of Xcopri for adults with partial-onset seizures, with the drug able to be crushed, mixed with water and administered by mouth as an oral suspension or via a nasogastric tube.

On April 11, which marks World Parkinson’s Night, the patient-led organization PD Avengers will launch Spark the Night, a global initiative dedicated to raising awareness for Parkinson’s disease.

Vagus nerve stimulation surgeries were relatively safe, with complication rates low but differing depending on the type of procedure and presence of complications, researchers reported in Brain and Spine.

A Houston-area neurohealth company announced completion of a full production test run, along with usability, feasibility design verification and electrical safety testing for its noninvasive, frequency-based deep brain stimulation device.

For childbearing aged women with idiopathic generalized epilepsy, switching medication from valproate to levetiracetam compared with lamotrigine decreased seizure recurrence at 24 months, according to research from Neurology.

To mark this April as Parkinson’s Awareness Month, the Parkinson’s Foundation has created the #ABCsofPD to provide information about relevant symptoms, statistics and treatments.